BCAB BioAtla, Inc.
Biological Products, (No Diagnostic Substances) · OTC · SEC CIK 1826892 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY63.6%
TTM EPS YoY177.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-277.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets4,031.1%
Debt / equity—
Current ratio0.05x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.62x
Accruals ratio-105.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $43.57M | $63.09M |
| SG&A expense | $17.73M | $21.85M |
| Operating income | -$59.30M | -$73.94M |
| Income tax | $0 | $0 |
| Net income | -$59.61M | -$69.78M |
| EBITDA | -$58.93M | -$73.02M |
| EPS (basic) | -1.01 | -1.44 |
| EPS (diluted) | -1.01 | -1.44 |
| Weighted avg. shares (diluted) | 58.83M | 48.57M |
| Balance sheet | ||
| Cash & equivalents | $7.12M | $49.05M |
| Receivables | $0 | — |
| Current assets | $8.01M | $51.23M |
| PP&E, net | $120,000 | $678,000 |
| Total assets | $13.83M | $52.42M |
| Current liabilities | $21.92M | $14.54M |
| Total liabilities | $50.02M | $38.16M |
| Shareholders' equity | -$36.19M | $14.27M |
| Shares outstanding | 1.27M | 58.10M |
| Cash flow statement | ||
| Operating cash flow | -$48.20M | -$71.94M |
| Investing cash flow | — | $0 |
| Financing cash flow | $6.28M | $9.51M |
| Depreciation & amortization | $373,000 | $925,000 |
| Stock-based compensation | $5.43M | $8.92M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.